Notice of administration of November 2025 licensure exams for pharmacy personnel
The Pharmacy and Medicines Regulatory Authority (PMRA) hereby announces that the November 2025 Licensure examinations for pharmacists, pharmacy technologists and pharmacy assistants will be administered as follows:
| MZUZU | BLANTYRE | LILONGWE | |
| TIME | 08h00 | 08h00 | 08h00 |
| DATES | 27th November, 2025 (Written exams for all) | 27th November, 2025 (Written exams for all) | 27th November, 2025 (Written exams for all) |
| 28th November, 2025 (Oral exam for pharmacists) | 28th November, 2025 (Oral exam for pharmacists) | 28th November, 2025 (Oral exam for pharmacists) | |
| VENUE | Grand Palace Hotel | Crossroads Hotel | Crossroads Hotel |
To be eligible to sit for the exams, candidates must meet the prescribed requirements, which can be found on the PMRA website ctechlogic.com/pmra/.
Application Process
Applications for the exams will be accepted online through Pharmacy Personnel Licensing portal. Candidates are advised to carefully read and follow the instructions below:
- To access the portal: Go to E-Services menu on the PMRA website: ctechlogic.com/pmra/ then select Pharmacy Personnel Licensing Portal.
- Create an account: Fill in the required general information and click “Create account”.
- Upload the required documents under My Profile including passport-size photo, proof of identification (National ID or Passport Biopage) and proof of qualification (copy of certificate, nofication of results or academic transcript).
- Create application: Under My Applications, click on “create an application” and select NOVEMBER LICENSURE EXAMINATION_2025 and your preferred centre.
- Submit the application: Click Apply to submit your application.
Application Review Process
All applications will be reviewed for completeness and eligibility. Candidates who meet the eligibility criteria will be issued with Application Number and bank payment details for them to proceed to pay applicable exam registration fees.
Once payment is made, upload proof of payment under the application session (click Application).
Confirmation
Once payment is confirmed by the Authority, candidates will receive examination number.
Tracking Application Status
Candidates can track the status of their application by logging into their account on the Pharmacy Personnel Licensing portal and checking the “My Applications” section.
Please note that the online application for the November 2025 licensure examinations starts on Saturday, 25th October, 2025 and closes on Saturday, 22nd November, 2025.
For more information and/ or assistance please contact PMRA on 0881790993 / 0999379544 or email at info@pmra.mw.
The Director General
Pharmacy and Medicines Regulatory Authority
P.O. Box 30241
Lilongwe 3.
Email: info@pmra.mw
Date of Issue: 25th October, 2025
WHO alert on substandard (contaminated) oral liquid medicines
ThePharmacy and Medicines Regulatory Authority (PMRA) is informing stakeholders and the public that the World Health Organisation (WHO) has issued an alert concerning three substandard (contaminated) oral liquid medicines identified in India and reported to WHO on 8th October, 2025.
The affected products are oral liquid medicines containing active ingredients commonly used to relieve symptoms of the common cold, flu, or cough. The contaminated oral liquid medicines have been identified to be specific batches of COLDRIF, Respifresh TR and ReLife, manufactured by Sresan Pharmaceutical, Rednex Pharmaceuticals, and Shape Pharma, respectively. The three products are considered substandard as they fail to meet their quality standards and specifications, making them unsafe.
According to WHO, none of the contaminated oral liquid medicines have been exported from India and that there is no evidence of illegal export.
PMRA is assuring stakeholders and the public that none of the three manufacturers have registered their products with PMRA making it very unlikely for the contaminated batches to be available in the country. However, in case anyone has these products, PMRA recommends that they should not use them and report to the Authority immediately.
PMRA urges pharmaceutical importers, retailers, healthcare workers, and consumers to report any suspected substandard or falsified medicines or adverse drug reactions to any healthcare facility and to the PMRA.
The Authority remains committed to ensuring medicines and allied substances in the country meet quality, safety, and efficacy standards as mandated by the PMRA Act, 2019.
Full details of the alert are available on: Medical Product Alert N°5/2025
For media enquiries, please contact PMRA Public Relations Officer on +265 899 567 365 or email at jjosiah@pmra.mw